| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gia Han Le, Sabrina Wong, Sebastian Badulescu, Hezekiah Au, Joshua D Di Vincenzo, Hartej Gill, Lee Phan, Taeho Greg Rhee, Roger Ho, Kayla M Teopiz, Angela T H Kwan, Joshua D Rosenblat, Rodrigo B Mansur, Roger S McIntyr. Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review. Journal of affective disorders. 2024-04-03. PMID:38570038. |
serotonergic psychedelics (sps) (i.e., psilocybin, lysergic acid diethylamide (lsd)) and ketamine represent new investigational and established treatments in mood disorders respectively. |
2024-04-03 |
2024-04-06 |
human |
| Valerio Ricci, Domenico De Berardis, Giuseppe Main. Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review. Healthcare (Basel, Switzerland). vol 12. issue 3. 2024-02-10. PMID:38338224. |
this review comprehensively investigates various substances, such as cannabinoids, cocaine, amphetamines, and lsd, which exhibit a greater propensity for inducing psychosis. |
2024-02-10 |
2024-02-12 |
Not clear |
| Mark A Geye. A brief historical overview of psychedelic research. Biological psychiatry. Cognitive neuroscience and neuroimaging. 2023-11-24. PMID:38000715. |
classical serotonergic psychedelics such as lysergic acid diethylamide (lsd) or the naturally occurring compounds psilocybin and mescaline produce profound changes in mood, thought, intuition, sensory perception, the experience of time and space, and even the experience of self. |
2023-11-24 |
2023-11-28 |
Not clear |
| Lindsay P Cameron, Joseph Benetatos, Vern Lewis, Emma M Bonniwell, Alaina M Jaster, Rafael Moliner, Eero Castrén, John D McCorvy, Mikael Palner, Argel Aguilar-Valle. Beyond the 5-HT The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 43. issue 45. 2023-11-08. PMID:37940583. |
beyond the 5-ht serotonergic psychedelics, such as psilocybin and lsd, have garnered significant attention in recent years for their potential therapeutic effects and unique mechanisms of action. |
2023-11-08 |
2023-11-20 |
Not clear |
| Matthew B Wall, Rebecca Harding, Rayyan Zafar, Eugenii A Rabiner, David J Nutt, David Erritzo. Neuroimaging in psychedelic drug development: past, present, and future. Molecular psychiatry. 2023-09-27. PMID:37759038. |
'classic' serotonergic psychedelics, such as psilocybin and lysergic acid diethylamide (lsd), which have a key locus of action at the 5-ht2a receptor, form the main focus of this movement, but substances including ketamine, 3,4-methylenedioxymethamphetamine (mdma) and ibogaine also hold promise. |
2023-09-27 |
2023-10-07 |
human |
| Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, Dean Calhou. The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits. Journal of applied toxicology : JAT. 2023-08-30. PMID:37646119. |
serotonergic psychedelics, such as lysergic acid diethylamide (lsd), psilocybin, dimethyltryptamine (dmt), and 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt), are currently being investigated for the treatment of psychiatric disorders such as depression and anxiety. |
2023-08-30 |
2023-09-07 |
Not clear |
| Miriam Cotaina, Marc Peraire, Mireia Boscá, Iván Echeverria, Ana Benito, Gonzalo Har. Substance Use in the Transgender Population: A Meta-Analysis. Brain sciences. vol 12. issue 3. 2022-03-25. PMID:35326322. |
these articles included data on current tobacco use, current tobacco use disorder, current alcohol use, current alcohol use disorder, lifetime substance (all) use, current substance use (excluding tobacco and alcohol), current use of specific substances (excluding tobacco and alcohol and including cocaine, amphetamines, methamphetamines, ecstasy, stimulants, heroin, opiates, cannabis, marijuana, lsd, hallucinogens, steroids, inhalants, sedatives, ritalin or adderall, diet pills, cold medicine, prescription medications, polysubstance, other club drugs, and other illegal drugs), and current substance use disorder (excluding tobacco and alcohol). |
2022-03-25 |
2023-08-13 |
human |
| Kelly Francisco da Cunha, Karina Diniz Oliveira, Marilyn A Huestis, Jose Luiz Cost. Screening of 104 New Psychoactive Substances (NPS) and Other Drugs of Abuse in Oral Fluid by LC-MS-MS. Journal of analytical toxicology. vol 44. issue 7. 2020-10-14. PMID:32685960. |
the aim of this research was to develop and validate a sensitive screening method for 104 drugs of abuse, including synthetic cannabinoids, synthetic cathinones, fentanyl analogues, phenethylamines and other abused psychoactive compounds (i.e., thc, mdma, lsd and their metabolites) in oral fluid by liquid chromatography-tandem mass spectrometry (lc-ms-ms). |
2020-10-14 |
2023-08-13 |
Not clear |
| Rémi Corne, Raymond Mongea. [Neurotrophic mechanisms of psychedelic therapy]. Biologie aujourd'hui. vol 213. issue 3-4. 2020-05-18. PMID:31829932. |
serotonergic psychedelics such as psilocybin and lysergic acid diethylamide (lsd) are gaining attention as potential treatments for depression and addiction, similarly to 3,4-methylenedioxymethamphetamine (mdma) for post-traumatic stress disorder (ptsd), and ibogaine for addiction. |
2020-05-18 |
2023-08-13 |
Not clear |
| Pietro Papa, Antonella Valli, Marcello Di Tuccio, Giampietro Frison, Flavio Zancanaro, Eleonora Buscaglia, Carlo Alessandro Locatell. Analytically Confirmed Intoxication by 4-Fluoromethylphenidate, an Analog of Methylphenidate. Journal of analytical toxicology. vol 43. issue 5. 2020-01-07. PMID:30843073. |
analyses for classic drugs (opiates, methadone, cocaine, cannabis metabolites, amphetamines, ecstasy and lsd), ethanol, qualitative full screen by gas chromatography-mass spectrometry and targeted analysis for 50 nps by liquid chromatography-tandem mass spectrometry tested negative; comorbidities were excluded, too. |
2020-01-07 |
2023-08-13 |
Not clear |
| Petra Strajhar, Patrick Vizeli, Melanie Patt, Patrick C Dolder, Denise V Kratschmar, Matthias E Liechti, Alex Odermat. Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study. The Journal of steroid biochemistry and molecular biology. vol 186. 2019-05-21. PMID:30381248. |
the effects of the amphetamines on glucocorticoid production were similar to those that were previously reported for methylphenidate (60 mg) but weaker than those for the serotonin releaser 3,4-methylenedioxymethamphetamine (mdma; 125 mg) or direct serotonin receptor agonist lysergic acid diethylamide (lsd; 0.2 mg). |
2019-05-21 |
2023-08-13 |
human |
| Anna Rickli, Olivier D Moning, Marius C Hoener, Matthias E Liecht. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 26. issue 8. 2018-01-23. PMID:27216487. |
several tryptamines, including psilocin, dmt, dipt, 4-oh-dipt, and 4-oh-met, interacted with the serotonin transporter and partially the norepinephrine transporter, similar to 3,4-methylenedioxymethamphetamine but in contrast to lsd and mescaline. |
2018-01-23 |
2023-08-13 |
human |
| Anna Rickli, Olivier D Moning, Marius C Hoener, Matthias E Liecht. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 26. issue 8. 2018-01-23. PMID:27216487. |
lsd but not the tryptamines interacted with adrenergic and dopaminergic receptors. |
2018-01-23 |
2023-08-13 |
human |
| Anna Rickli, Olivier D Moning, Marius C Hoener, Matthias E Liecht. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 26. issue 8. 2018-01-23. PMID:27216487. |
binding affinity to the 5-ht2a receptor was lower for all of the tryptamines, including psilocin and dmt, compared with lsd and correlated with the reported psychoactive doses in humans. |
2018-01-23 |
2023-08-13 |
human |
| D E Nichols, M W Johnson, C D Nichol. Psychedelics as Medicines: An Emerging New Paradigm. Clinical pharmacology and therapeutics. vol 101. issue 2. 2017-05-29. PMID:28019026. |
scientific interest in serotonergic psychedelics (e.g., psilocybin and lsd; 5-ht |
2017-05-29 |
2023-08-13 |
Not clear |
| David Baumeister, Luis M Tojo, Derek K Trac. Legal highs: staying on top of the flood of novel psychoactive substances. Therapeutic advances in psychopharmacology. vol 5. issue 2. 2015-08-05. PMID:26240749. |
this review aims to circumscribe a quick moving and growing field, and to categorize nps into five major groups based upon their 'parent' compounds: stimulants similar to cocaine, amphetamines and ecstasy; cannabinoids; benzodiazepine based drugs; dissociatives similar to ketamine and phencyclidine (pcp); and those modelled after classic hallucinogens such as lsd and psilocybin. |
2015-08-05 |
2023-08-13 |
human |
| Jane Carlisle Maxwel. Psychoactive substances--some new, some old: a scan of the situation in the U.S. Drug and alcohol dependence. vol 134. 2014-08-16. PMID:24140401. |
users of the synthetic cannabinoids, synthetic cathinones, phenethylamines, tryptamines, lsd, mdma, and mushrooms tended to be young and male. |
2014-08-16 |
2023-08-12 |
Not clear |
| Robin M Murray, Alessandra Paparelli, Paul D Morrison, Arianna Marconi, Marta Di Fort. What can we learn about schizophrenia from studying the human model, drug-induced psychosis? American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 162B. issue 7. 2014-05-27. PMID:24132898. |
research into the effects of lsd initiated the serotonergic model; amphetamines the dopamine hypothesis, pcp and ketamine the glutamatergic hypothesis, while most recently the effects of cannabis have provoked interest in the role of endocannabinoids in schizophrenia. |
2014-05-27 |
2023-08-12 |
human |
| Patrick Dawson, James D Moffat. Cardiovascular toxicity of novel psychoactive drugs: lessons from the past. Progress in neuro-psychopharmacology & biological psychiatry. vol 39. issue 2. 2013-03-19. PMID:22580238. |
the long use of ephedrine, amphetamines, cocaine, lsd and more recently 3,4-methylenedioxy-n-methylamphetamine (mdma; "ecstasy") allows us to predict with some confidence what cardiovascular risks are likely to be associated with novel psychoactive substances (nps). |
2013-03-19 |
2023-08-12 |
Not clear |
| Robert J Devlin, John A Henr. Clinical review: Major consequences of illicit drug consumption. Critical care (London, England). vol 12. issue 1. 2008-06-23. PMID:18279535. |
hallucinations may follow consumption of lsd, amphetamines, or cocaine. |
2008-06-23 |
2023-08-12 |
Not clear |